(Q33407349)

26 July 2017

High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia (English)

1 reference

26 July 2017

1 reference

1 reference

Yoko Nukui

1

1 reference

26 July 2017

Shuji Hatakeyama

2

1 reference

26 July 2017

Koh Okamoto

3

1 reference

26 July 2017

Takehito Yamamoto

4

1 reference

26 July 2017

Akihiro Hisaka

5

1 reference

26 July 2017

Hiroshi Suzuki

6

1 reference

26 July 2017

Nahoko Yata

7

1 reference

26 July 2017

Hiroshi Yotsuyanagi

8

1 reference

26 July 2017

Kyoji Moriya

9

1 reference

26 July 2017

language of work or name

English

0 references

publication date

26 April 2013

1 reference

Journal of Antimicrobial Chemotherapy

26 July 2017

1 reference

26 July 2017

68

1 reference

26 July 2017

9

1 reference

26 July 2017

2128-2133

1 reference

Linezolid: a review of safety and tolerability

26 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

A review of linezolid: the first oxazolidinone antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

A comparison of linezolid with glycopeptides in severe MRSA pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Pharmacologic options for CNS infections caused by resistant Gram-positive organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Thrombocytopenia associated with linezolid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Safety and tolerability of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Chronic liver disease increases the risk of linezolid-related thrombocytopenia in methicillin-resistant Staphylococcus aureus-infected patients after digestive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Mechanisms for linezolid-induced anemia and thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Appearance of ring sideroblasts in bone marrow during linezolid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Pharmacokinetics of linezolid in subjects with renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Determination of linezolid in human plasma by LC-MS-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence of anaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Renal function as a predictor of linezolid-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Population pharmacokinetics of linezolid in patients treated in a compassionate-use program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Pharmacokinetic studies of linezolid and teicoplanin in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Correlation between serum linezolid concentration and the development of thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Hematologic effects of linezolid: summary of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Linezolid-induced pure red blood cell aplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Linezolid and reversible myelosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKT133

21 January 2018

Identifiers

DOI

10.1093/JAC/DKT133

1 reference

26 July 2017

1 reference